Abstract

Future OncologyVol. 10, No. 15s Symposium PaperThe safety of resection post-selective internal radiation therapyFernando Rotellar, Fernando Pardo & Patricia Martínez-OrtegaFernando Rotellar*Author for correspondence: E-mail Address: frotellar@unav.es HPB & Liver Transplant Unit, Department of General & Abdominal Surgery, University Clinic of Navarre, University of Navarre, Avda. Pio XII no. 36, Pamplona, SpainSearch for more papers by this author, Fernando Pardo HPB & Liver Transplant Unit, Department of General & Abdominal Surgery, University Clinic of Navarre, University of Navarre, Avda. Pio XII no. 36, Pamplona, SpainSearch for more papers by this author & Patricia Martínez-Ortega HPB & Liver Transplant Unit, Department of General & Abdominal Surgery, University Clinic of Navarre, University of Navarre, Avda. Pio XII no. 36, Pamplona, SpainSearch for more papers by this authorPublished Online:5 Dec 2014https://doi.org/10.2217/fon.14.224AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: liver tumorsradioembolizationselective internal radiation therapysurgeryyttrium-90References1 Martinez-Ortega P, Pardo F, Sangro B. Surgical treatment and radioembolization. In: Liver Radioembolization with 90Y Microspheres (2nd Ed.). Bilbao JI, Reiser MF (Eds). Springer, Germany, 167–170 (2014).Google Scholar2 Oldhafer KJ, Donati M, Jenner RM et al. ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence. World J. Surg. 38(6), 1504–1509 (2014).Crossref, Medline, Google Scholar3 Iñarrairaegui M, Pardo F, Bilbao JI et al. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur. J. Surg. Oncol. 38(7), 594–601 (2012).Crossref, Medline, CAS, Google Scholar4 Fernández-Ros N, Silva N, Bilbao JI et al. Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension. HPB (Oxford) 16(3), 243–249 (2014).Crossref, Medline, Google Scholar5 Gulec SA, Pennington K, Hall M et al. Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections. World J. Surg. Oncol. 7, 6 (2009).Crossref, Medline, Google Scholar6 Berry DP. Liver resection post-selective internal radiation therapy – an overview. EJC Suppl. 10(3), 36–38 (2012).Crossref, Google Scholar7 Chua TC, Bester L, Akther J et al. Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases. Anticancer Res. 30(7), 3005–3007 (2010).Medline, Google Scholar8 Whitney R, Tatum C, Hahl M et al. Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J. Surg. Res. 166(2), 236–240 (2011).Crossref, Medline, Google Scholar9 Brown RE, Bower MR, Metzger TL et al. Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe? HPB (Oxford) 13(2), 91–95 (2011).Crossref, Medline, Google ScholarFiguresReferencesRelatedDetailsCited ByLiver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience25 January 2023 | Cancers, Vol. 15, No. 3Pure laparoscopic major liver resection after yttrium90 radioembolization: a case-matched series analysis of feasibility and outcomes28 February 2022 | Langenbeck's Archives of Surgery, Vol. 407, No. 3Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes26 March 2019 | Journal of Gastrointestinal Cancer, Vol. 51, No. 1 Vol. 10, No. 15s eToC Sign up Follow us on social media for the latest updates Metrics Downloaded 40 times History Published online 5 December 2014 Published in print November 2014 Information© Future Medicine LtdKeywordsliver tumorsradioembolizationselective internal radiation therapysurgeryyttrium-90Financial & competing interests disclosureF Rotellar and F Pardo have received honoraria and travel assistance from Sirtex Medical Ltd for presentations and/or participation in medical symposia and the European advisory board. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.The authors would like to thank Rae Hobbs (of Scribe Medical) for her editorial assistance in the development of this paper, funded by Sirtex Medical Ltd.PDF download

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call